Cargando…

Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital

Bloodstream infection caused by Acinetobacter baumannii has become a major clinical concern, especially multidrug-resistant A baumannii (MDRAB). The aim of this study was to identify the risk factors of nosocomial acquired MDRAB bacteremia and to determine the risk factors related to the mortality o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hua, Yao, Yake, Zhu, Bingquan, Ren, Danhong, Yang, Qing, Fu, Yiqi, Yu, Yunsong, Zhou, Jianying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456023/
https://www.ncbi.nlm.nih.gov/pubmed/30921191
http://dx.doi.org/10.1097/MD.0000000000014937
_version_ 1783409697103020032
author Zhou, Hua
Yao, Yake
Zhu, Bingquan
Ren, Danhong
Yang, Qing
Fu, Yiqi
Yu, Yunsong
Zhou, Jianying
author_facet Zhou, Hua
Yao, Yake
Zhu, Bingquan
Ren, Danhong
Yang, Qing
Fu, Yiqi
Yu, Yunsong
Zhou, Jianying
author_sort Zhou, Hua
collection PubMed
description Bloodstream infection caused by Acinetobacter baumannii has become a major clinical concern, especially multidrug-resistant A baumannii (MDRAB). The aim of this study was to identify the risk factors of nosocomial acquired MDRAB bacteremia and to determine the risk factors related to the mortality of patients with MDRAB bacteremia. Patients with nosocomial acquired A baumannii bacteremia were enrolled between January, 2013 and December, 2017 at the First Affiliated Hospital, School of Medicine, Zhejiang University. Medical records were reviewed, and the clinical and microbial characteristics were collected. Among the 338 patients suffering from A baumannii bacteremia, 274 patients were infected with MDRAB bacteremia. Bacteremia-related mortality was 46.4% for the overall sample; 56.2% for MDRAB bacteremia patients, 4.7% for non-MDRAB bacteremia patients. The identified risk factors for developing MDRAB bacteremia were previous exposure to carbapenems [odds ratio (OR) 5.78, P = .005] and penicillins+β-lactamase inhibitors (OR 4.29, P = .009). Primary bacteremia tended to develop non-MDR bacteremia (OR 0.10, P = .002). The risk factors for MDRAB bacteremia-related mortality were old age (OR 1.02, P = .036), a high Pitt bacteremia score (OR 1.32, P < .001), bacteremia occurring after severe pneumonia (OR 8.66, P < .001), while catheter-related infection (OR 0.47, P = .049) and operations for treating infection (OR 0.51, P = .043) may have a better outcome. Patients with MDRAB had a higher mortality rate. Patients with previous carbapenems and penicillins+β-lactamase inhibitor exposure are at an increased risk of MDRAB bacteremia, whereas patients with primary bacteremia tended to develop non-MDR bacteremia. The risk factors for MDRAB bacteremia-related mortality were old age, a high Pitt bacteremia score, and bacteremia occurring after severe pneumonia, whereas catheter-related infection and operations for the treatment of infection may have a better outcome.
format Online
Article
Text
id pubmed-6456023
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-64560232019-05-29 Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital Zhou, Hua Yao, Yake Zhu, Bingquan Ren, Danhong Yang, Qing Fu, Yiqi Yu, Yunsong Zhou, Jianying Medicine (Baltimore) Research Article Bloodstream infection caused by Acinetobacter baumannii has become a major clinical concern, especially multidrug-resistant A baumannii (MDRAB). The aim of this study was to identify the risk factors of nosocomial acquired MDRAB bacteremia and to determine the risk factors related to the mortality of patients with MDRAB bacteremia. Patients with nosocomial acquired A baumannii bacteremia were enrolled between January, 2013 and December, 2017 at the First Affiliated Hospital, School of Medicine, Zhejiang University. Medical records were reviewed, and the clinical and microbial characteristics were collected. Among the 338 patients suffering from A baumannii bacteremia, 274 patients were infected with MDRAB bacteremia. Bacteremia-related mortality was 46.4% for the overall sample; 56.2% for MDRAB bacteremia patients, 4.7% for non-MDRAB bacteremia patients. The identified risk factors for developing MDRAB bacteremia were previous exposure to carbapenems [odds ratio (OR) 5.78, P = .005] and penicillins+β-lactamase inhibitors (OR 4.29, P = .009). Primary bacteremia tended to develop non-MDR bacteremia (OR 0.10, P = .002). The risk factors for MDRAB bacteremia-related mortality were old age (OR 1.02, P = .036), a high Pitt bacteremia score (OR 1.32, P < .001), bacteremia occurring after severe pneumonia (OR 8.66, P < .001), while catheter-related infection (OR 0.47, P = .049) and operations for treating infection (OR 0.51, P = .043) may have a better outcome. Patients with MDRAB had a higher mortality rate. Patients with previous carbapenems and penicillins+β-lactamase inhibitor exposure are at an increased risk of MDRAB bacteremia, whereas patients with primary bacteremia tended to develop non-MDR bacteremia. The risk factors for MDRAB bacteremia-related mortality were old age, a high Pitt bacteremia score, and bacteremia occurring after severe pneumonia, whereas catheter-related infection and operations for the treatment of infection may have a better outcome. Wolters Kluwer Health 2019-03-15 /pmc/articles/PMC6456023/ /pubmed/30921191 http://dx.doi.org/10.1097/MD.0000000000014937 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Research Article
Zhou, Hua
Yao, Yake
Zhu, Bingquan
Ren, Danhong
Yang, Qing
Fu, Yiqi
Yu, Yunsong
Zhou, Jianying
Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital
title Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital
title_full Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital
title_fullStr Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital
title_full_unstemmed Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital
title_short Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital
title_sort risk factors for acquisition and mortality of multidrug-resistant acinetobacter baumannii bacteremia: a retrospective study from a chinese hospital
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456023/
https://www.ncbi.nlm.nih.gov/pubmed/30921191
http://dx.doi.org/10.1097/MD.0000000000014937
work_keys_str_mv AT zhouhua riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital
AT yaoyake riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital
AT zhubingquan riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital
AT rendanhong riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital
AT yangqing riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital
AT fuyiqi riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital
AT yuyunsong riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital
AT zhoujianying riskfactorsforacquisitionandmortalityofmultidrugresistantacinetobacterbaumanniibacteremiaaretrospectivestudyfromachinesehospital